News stories about Castlight Health, inc. (NYSE:CSLT) have been trending positive on Monday, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Castlight Health, inc. earned a media sentiment score of 0.29 on Accern’s scale. Accern also gave media coverage about the software maker an impact score of 46.9255911471131 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:
- Castlight Health, inc. (CSLT) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com)
- Castlight Health, Inc. breached its 50 day moving average in a Bearish Manner : CSLT-US : October 30, 2017 (finance.yahoo.com)
- Castlight Health : reports 3Q loss (4-traders.com)
- Canaccord Genuity Reaffirms “Buy” Rating for Castlight Health, inc. (CSLT) (americanbankingnews.com)
- Castlight Health, inc. (CSLT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS (americanbankingnews.com)
Shares of Castlight Health, inc. (NYSE CSLT) traded down 1.27% during trading on Monday, hitting $3.90. The stock had a trading volume of 200,252 shares. The firm’s 50-day moving average is $4.23 and its 200 day moving average is $4.05. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The firm’s market cap is $513.58 million.
Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.02. Castlight Health, inc. had a negative return on equity of 35.70% and a negative net margin of 45.14%. The firm had revenue of $34.60 million during the quarter, compared to analysts’ expectations of $34.61 million. During the same quarter last year, the firm earned ($0.05) earnings per share. The business’s revenue for the quarter was up 35.7% on a year-over-year basis. On average, analysts expect that Castlight Health, inc. will post ($0.23) EPS for the current year.
A number of analysts have issued reports on the company. Zacks Investment Research raised Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 price objective on the stock in a research note on Monday. ValuEngine downgraded Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Thursday, August 10th. Canaccord Genuity reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Castlight Health, inc. in a research note on Thursday. Dougherty & Co reaffirmed a “buy” rating on shares of Castlight Health, inc. in a research note on Thursday, August 17th. Finally, BidaskClub downgraded Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Wednesday, October 18th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. Castlight Health, inc. has a consensus rating of “Hold” and a consensus target price of $5.22.
ILLEGAL ACTIVITY WARNING: This story was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.com-unik.info/2017/10/30/castlight-health-inc-cslt-earns-daily-coverage-optimism-rating-of-0-29.html.
In related news, CFO Mangini Siobhan Nolan sold 28,639 shares of the stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $3.66, for a total value of $104,818.74. Following the completion of the sale, the chief financial officer now owns 41,622 shares of the company’s stock, valued at $152,336.52. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Giovanni M. Colella sold 23,000 shares of the stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $4.06, for a total value of $93,380.00. Following the completion of the sale, the insider now directly owns 78,906 shares of the company’s stock, valued at approximately $320,358.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 208,287 shares of company stock valued at $795,240. Insiders own 24.38% of the company’s stock.
Castlight Health, inc. Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
What are top analysts saying about Castlight Health inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Castlight Health inc. and related companies.